\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationCampus Cyber, Paris
ProgrammesThis event gathers European-wide innovators and practitioners. It focuses on connecting individuals who are actively seeking consortium partners and to bring their game-changing ideas and novel technologies to life, addressing the challenges outlined in Horizon Europe’s Civil Security for Society 2023-2024 Work Programme.
The event will feature top-level keynote speeches, expert panel discussions as well as ground-breaking pitch sessions. It will offer significant networking opportunities and information on Horizon Europe Security Calls.
The SMI2G brokerage event is organised by: The EARTO Working Group Security and Defence research, the SEREN network, EOS, IMG-S, ECSO, CMINE and is supported by the Ministère de l’Enseignement Supérieur et de la Recherche, Campus Cyber and ENLETS.
The event will be held in presence.
To register, check out the event page here.
For further information, please contact the organisers at enquiries@smi2g.eu
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
